Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trial
Titel:
Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trial
Auteur:
Ford, Hugo E R Marshall, Andrea Bridgewater, John A Janowitz, Tobias Coxon, Fareeda Y Wadsley, Jonathan Mansoor, Wasat Fyfe, David Madhusudan, Srinivasan Middleton, Gary W Swinson, Daniel Falk, Stephen Chau, Ian Cunningham, David Kareclas, Paula Cook, Natalie Blazeby, Jane M Dunn, Janet A
Verschenen in:
Lancet oncology
Paginering:
Jaargang 15 (2014) nr. 1 pagina's 9 p.
Jaar:
2014
Inhoud:
Uitgever:
Ford et al. Open Access article distributed under the terms of CC BY